C3 Jian Initiates Phase 2 Clinical Trial of Anti-Cavity Drug
07 mars 2014 18h40 HE
|
C3 Jian, Inc.
LOS ANGELES, March 7, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that the first Phase 2 Clinical Trial for its novel drug,...
C3 Jian Completes C16G2 Phase 1 Clinical Study Enrollment
19 févr. 2013 14h50 HE
|
C3 Jian, Inc.
LOS ANGELES, Feb. 19, 2013 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced the successful completion of Phase 1 study enrollment for its...